{"name": "Pulmatrix",
 "permalink": "pulmatrix",
 "crunchbase_url": "http://www.crunchbase.com/company/pulmatrix",
 "homepage_url": "http://www.pulmatrix.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@pulmatrix.com",
 "phone_number": "781-357-2333",
 "description": "Inhaled Respiratory Disease Therapies",
 "created_at": "Thu Nov 12 01:38:05 UTC 2009",
 "updated_at": "Tue Sep 04 13:03:17 UTC 2012",
 "overview": "\u003Cp\u003EPulmatrix, Inc., a clinical stage biopharmaceutical company, develops inhaled therapies for the treatment, prevention, and transmission control of infectious and progressive respiratory diseases. It offers inhaled cationic airway lining modulator drugs, which stimulate host defense mechanisms within the airway to treat and prevent influenza, rhinovirus, and chronic pulmonary diseases. The company was founded in 2003 and is based in Lexington, Massachusetts.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       48],
      "assets/images/resized/0006/5853/65853v1-max-150x150.png"],
     [[188,
       61],
      "assets/images/resized/0006/5853/65853v1-max-250x250.png"],
     [[188,
       61],
      "assets/images/resized/0006/5853/65853v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Robert",
      "last_name": "Clarke",
      "permalink": "robert-clarke",
      "image": null}},
   {"is_past": false,
    "title": "CBO",
    "person":
     {"first_name": "Eva",
      "last_name": "Jack",
      "permalink": "eva-jack",
      "image": null}},
   {"is_past": false,
    "title": "Board Observer",
    "person":
     {"first_name": "Kevin",
      "last_name": "Bitterman",
      "permalink": "kevin-bitterman",
      "image":
       {"available_sizes":
         [[[100,
            150],
           "assets/images/resized/0025/1971/251971v1-max-150x150.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1971/251971v1-max-250x250.jpg"],
          [[150,
            225],
           "assets/images/resized/0025/1971/251971v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Kurt",
      "last_name": "Graves",
      "permalink": "kurt-graves",
      "image": null}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "Terry",
      "last_name": "McGuire",
      "permalink": "terry-mcguire-2",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0002/8631/28631v3-max-150x150.png"],
          [[184,
            184],
           "assets/images/resized/0002/8631/28631v3-max-250x250.png"],
          [[184,
            184],
           "assets/images/resized/0002/8631/28631v3-max-450x450.png"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$53.4M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.xconomy.com/boston/2009/11/02/pulmatrix-scores-30m-venture-round-for-lung-drug-that-defends-against-multiple-bugs/",
    "source_description": "Xconomy Boston",
    "raised_amount": 30200000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 11,
    "funded_day": 2,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Bioventures",
         "permalink": "novartis-bioventures",
         "image":
          {"available_sizes":
            [[[150,
               59],
              "assets/images/resized/0006/1683/61683v1-max-150x150.png"],
             [[250,
               98],
              "assets/images/resized/0006/1683/61683v1-max-250x250.png"],
             [[380,
               150],
              "assets/images/resized/0006/1683/61683v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.masshightech.com/stories/2009/03/09/weekly12-Pulmatrix-pulls-in-3M-in-new-venture-round.html",
    "source_description": "Mass High Tech",
    "raised_amount": 3500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2009,
    "funded_month": 3,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "grant",
    "source_url": "https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=32\u0026aid=DJFVW00020101214e6ce000b8\u0026r=Rss\u0026s=DJFVW",
    "source_description": "Pulmatrix Secures $5.7M Darpa Grant, Hires Eva Jack As CBO",
    "raised_amount": 5700000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 12,
    "funded_day": 14,
    "investments":
     []},
   {"round_code": "b",
    "source_url": "http://eon.businesswire.com/news/eon/20110815005533/en/pulmatrix/inhaled-drug-delivery/respiratory-disease",
    "source_description": "Pulmatrix Secures a $14 million Financing to Advance Clinical Programs in COPD and Cystic Fibrosis",
    "raised_amount": 14000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 8,
    "funded_day": 15,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Polaris Partners",
         "permalink": "polaris-partners",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0001/1153/11153v1-max-150x150.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-250x250.png"],
             [[163,
               40],
              "assets/images/resized/0001/1153/11153v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "5AM Ventures",
         "permalink": "5am-ventures",
         "image":
          {"available_sizes":
            [[[150,
               104],
              "assets/images/resized/0004/7316/47316v2-max-150x150.jpg"],
             [[250,
               173],
              "assets/images/resized/0004/7316/47316v2-max-250x250.jpg"],
             [[288,
               200],
              "assets/images/resized/0004/7316/47316v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "ARCH Venture Partners",
         "permalink": "arch-venture-partners",
         "image":
          {"available_sizes":
            [[[150,
               31],
              "assets/images/resized/0003/6165/36165v2-max-150x150.png"],
             [[250,
               51],
              "assets/images/resized/0003/6165/36165v2-max-250x250.png"],
             [[300,
               62],
              "assets/images/resized/0003/6165/36165v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "99 Hayden Avenue",
    "address2": "Suite 390",
    "zip_code": "02421",
    "city": "Lexington",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        82],
       "assets/images/resized/0007/5224/75224v1-max-150x150.jpg"],
      [[250,
        137],
       "assets/images/resized/0007/5224/75224v1-max-250x250.jpg"],
      [[450,
        246],
       "assets/images/resized/0007/5224/75224v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}